Product in Healthtech

Chris Hoyd, Vynyl

Product leaders guide decisions around what should be built. They are interpreters that make sense of what’s happening as their organizations evolve rapidly. Product leaders balance business priorities, customer demands, and competitive pressures. Both strategic and tactical, this highly visible discipline is emerging as one that can be very difficult to execute well in the healthcare space. The floodgates of funding, digitization, and internet-enabled competition are open. Businesses that build the best product the fastest will see outsized returns. Join the conversation about how healthcare product managers, designers, researchers and other stakeholders can add meaningful value to their teams. Learn how the best product leaders optimize decision quality for entire organizations, increase development velocity, and navigate the unique constraints and opportunities in healthcare.

  1. Radical Clarity in Drug Pricing: How Rescription Uses the 340B Program and Patented Tech to Lower Costs

    04/22/2025

    Radical Clarity in Drug Pricing: How Rescription Uses the 340B Program and Patented Tech to Lower Costs

    In this episode of Product in Healthtech, we reconnect with Scott Martin, founder and CEO of Rescription, to discover how his company has evolved since our previous conversation. Topics covered: Rescription's "radical clarity" approach to transforming prescription drug costsHow Rescription leverages the 340B federal program as intended to benefit both health systems and patientsResults from partnerships with Bergen New Bridge and Baton Rouge General, showing 27-35% savingsWhy patients under Rescription's model receive zero-dollar copays for prescriptionsThe patent-pending adjudication technology developed with Vynyl that enables upfront processing at scaleRescription's ambitious expansion plans across 14 states and 15 additional health systemsKey moments: [01:16] Scott explains how Rescription's model differs from traditional PBMs[03:09] Clarifying misconceptions about the 340B program[05:14] Updates on partnerships with Bergen New Bridge and Baton Rouge General[07:25] How Rescription addresses pharmaceutical manufacturer pushback[09:24] Details on Rescription's patent-pending adjudication technology[11:15] Future expansion plans and new service offeringsResources mentioned: Wall Street Journal article featuring Rescription: https://www.wsj.com/health/healthcare/prescription-drug-prices-340b-pharmacy-benefit-plans-6834cc08Follow Product in Healthtech: Website: productinhealthtech.comLinkedIn: Product in HealthtechEmail: info@productinhealthtech.com Product in Healthtech is community for healthtech product leaders, by product leaders. For more information, and to sign up for our free webinars, visit www.productinhealthtech.com.

    14 min

Ratings & Reviews

5
out of 5
4 Ratings

About

Product leaders guide decisions around what should be built. They are interpreters that make sense of what’s happening as their organizations evolve rapidly. Product leaders balance business priorities, customer demands, and competitive pressures. Both strategic and tactical, this highly visible discipline is emerging as one that can be very difficult to execute well in the healthcare space. The floodgates of funding, digitization, and internet-enabled competition are open. Businesses that build the best product the fastest will see outsized returns. Join the conversation about how healthcare product managers, designers, researchers and other stakeholders can add meaningful value to their teams. Learn how the best product leaders optimize decision quality for entire organizations, increase development velocity, and navigate the unique constraints and opportunities in healthcare.